Skip to main content

Spectrum: Autism Research News

Tag: treatments

November 2010

‘Daydreaming’ circuit implicated in autism, attention deficit

by  /  24 November 2010

Areas of the brain that are active when people are daydreaming or sleeping, and quiet when they are engaged in a task, are imperfectly synchronized in people with autism and attention deficit hyperactivity disorder, researchers say.

Comments

Antibiotic proves promising as fragile X treatment

by  /  19 November 2010

Minocycline, an antibiotic approved to treat various infections including acne, can increase vocalizations and provide long-lasting improvements in anxiety in a fragile X mouse model, according to two posters presented at the Society for Neuroscience annual meeting in San Diego.

Comments

Mouse model hints at Alzheimer’s therapies for fragile X

by  /  19 November 2010

Lowering the levels of proteins associated with Alzheimer’s disease can improve symptoms of fragile X syndrome in mice, according to a poster presented Wednesday at the Society for Neuroscience annual meeting in San Diego.

Comments

Congressman Kennedy calls for neuroscience ‘moonshot’

by  /  19 November 2010

Sharing stories about his own family’s struggles with neurological disease, Patrick J. Kennedy, a Democratic Congressman, on Monday called for a focused national program to uncover the causes and treatments for brain disorders. The challenge today, he told SFARI, is to devote enough resources for research on disorders such as autism.

Comments

Immune protein alters development in young mice

by  /  18 November 2010

Pregnant mice injected with the immune protein interleukin-6 give birth to pups that are less social than normal, an effect that results from the over-activation of two pathways critical in neurodevelopment, researchers reported Tuesday at the Society for Neuroscience annual meeting in San Diego.

Comments

Lithium targets key enzyme to improve fragile X symptoms

by  /  18 November 2010

Lithium ameliorates some of the cognitive and behavioral deficits associated with fragile X syndrome by blocking GSK-3, an enzyme that plays a key role in development, researchers said Wednesday at the Society for Neuroscience annual meeting in San Diego.

Comments

Inner receptors may be important for fragile X treatment

by  /  18 November 2010

Contrary to popular belief, receptors both outside and inside a cell regulate a cellular pathway that is overactive in people with fragile X syndrome, researchers reported Tuesday at the Society for Neuroscience annual meeting in San Diego. The finding could have significant implications for drug treatments of fragile X syndrome.

Comments

Tuberous sclerosis mice have fewer synaptic proteins

by  /  17 November 2010

A study of mice with tuberous sclerosis — a single-gene disorder that is related to autism — suggests that most forms of autism share a common feature: an imbalance of proteins at the synapse, the junction between neurons. The work was presented Monday at the Society for Neuroscience annual meeting in San Diego.

Comments

Stem cell assay reveals early development of Rett neurons

by  /  16 November 2010

Researchers have developed the first stem cell system that makes it possible to study the early development of neurons from people with Rett syndrome, a rare disorder on the autism spectrum.

Comments

Prairie vole study finds new drug that boosts oxytocin

by  /  15 November 2010

A drug already in clinical trials as a tanning compound raises brain levels of oxytocin — a hormone and neurotransmitter involved in social bonding — researchers reported Sunday at the Society for Neuroscience annual meeting in San Diego. Higher levels of oxytocin can help animals recognize their mates and turn to a friend for help, according to two posters presented at the meeting.

Comments